| Evaluation of galcanezumab for the prevention of episodic migraine: the EVOLVE-1 randomized clinical trial VL Stauffer, DW Dodick, Q Zhang, JN Carter, J Ailani, RR Conley JAMA neurology 75 (9), 1080-1088, 2018 | 606 | 2018 |
| Ubrogepant for the treatment of migraine DW Dodick, RB Lipton, J Ailani, K Lu, M Finnegan, JM Trugman, ... New England Journal of Medicine 381 (23), 2230-2241, 2019 | 335 | 2019 |
| The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice J Ailani, RC Burch, MS Robbins, ... Headache: The Journal of Head and Face Pain 61 (7), 1021-1039, 2021 | 314 | 2021 |
| Effect of ubrogepant vs placebo on pain and the most bothersome associated symptom in the acute treatment of migraine: the ACHIEVE II randomized clinical trial RB Lipton, DW Dodick, J Ailani, K Lu, M Finnegan, A Szegedi, ... Jama 322 (19), 1887-1898, 2019 | 252 | 2019 |
| Expert consensus recommendations for the performance of peripheral nerve blocks for headaches–a narrative review A Blumenfeld, A Ashkenazi, U Napchan, SD Bender, BC Klein, R Berliner, ... Headache: The Journal of Head and Face Pain 53 (3), 437-446, 2013 | 237 | 2013 |
| Atogepant for the preventive treatment of migraine J Ailani, RB Lipton, PJ Goadsby, H Guo, R Miceli, L Severt, M Finnegan, ... New England Journal of Medicine 385 (8), 695-706, 2021 | 219 | 2021 |
| The sphenopalatine ganglion: anatomy, pathophysiology, and therapeutic targeting in headache MS Robbins, CE Robertson, E Kaplan, J Ailani, L Charleston IV, ... Headache: The Journal of Head and Face Pain 56 (2), 240-258, 2016 | 194 | 2016 |
| Board of Directors of the American Headache Society. The American Headache Society Consensus Statement: update on integrating new migraine treatments into clinical practice J Ailani, RC Burch, MS Robbins Headache 61 (7), 1021-1039, 2021 | 192 | 2021 |
| Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial PJ Goadsby, DW Dodick, J Ailani, JM Trugman, M Finnegan, K Lu, ... The Lancet Neurology 19 (9), 727-737, 2020 | 180 | 2020 |
| Migraine care in the era of COVID‐19: Clinical pearls and plea to insurers CL Szperka, J Ailani, R Barmherzig, BC Klein, MT Minen, ... Headache: The Journal of Head and Face Pain 60 (5), 833-842, 2020 | 122 | 2020 |
| Effects of intravenous eptinezumab vs placebo on headache pain and most bothersome symptom when initiated during a migraine attack: a randomized clinical trial PK Winner, P McAllister, G Chakhava, J Ailani, A Ettrup, MK Josiassen, ... Jama 325 (23), 2348-2356, 2021 | 85 | 2021 |
| Long‐term safety evaluation of ubrogepant for the acute treatment of migraine: phase 3, randomized, 52‐week extension trial J Ailani, RB Lipton, S Hutchinson, K Knievel, K Lu, M Butler, SY Yu, ... Headache: The Journal of Head and Face Pain 60 (1), 141-152, 2020 | 85 | 2020 |
| OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine over one year of treatment: pooled results from the PREEMPT randomized clinical trial program RB Lipton, NL Rosen, J Ailani, RE DeGryse, PJ Gillard, SF Varon Cephalalgia 36 (9), 899-908, 2016 | 81 | 2016 |
| An up to date review of pseudotumor cerebri syndrome JG Burkett, J Ailani Current neurology and neuroscience reports 18, 1-7, 2018 | 77 | 2018 |
| Ubrogepant, an acute treatment for migraine, improved patient‐reported functional disability and satisfaction in 2 single‐attack phase 3 randomized trials, ACHIEVE I and II DW Dodick, RB Lipton, J Ailani, RB Halker Singh, AR Shewale, S Zhao, ... Headache: The Journal of Head and Face Pain 60 (4), 686-700, 2020 | 58 | 2020 |
| Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials LS Loo, J Ailani, J Schim, S Baygani, HP Hundemer, M Port, JH Krege The journal of headache and pain 20, 1-11, 2019 | 51 | 2019 |
| Rapid onset of effect of galcanezumab for the prevention of episodic migraine: analysis of the EVOLVE studies HC Detke, BA Millen, Q Zhang, K Samaan, J Ailani, DW Dodick, ... Headache: The Journal of Head and Face Pain 60 (2), 348-359, 2020 | 48 | 2020 |
| A clinical approach to addressing diet with migraine patients M Slavin, J Ailani Current neurology and neuroscience reports 17, 1-8, 2017 | 47 | 2017 |
| Systematic review of preventive and acute treatment of menstrual migraine HC Nierenburg, J Ailani, M Malloy, S Siavoshi, NN Hu, N Yusuf Headache: The Journal of Head and Face Pain 55 (8), 1052-1071, 2015 | 47 | 2015 |
| Discontinuation of acute prescription medication for migraine: results from the chronic migraine epidemiology and outcomes (CaMEO) study RB Lipton, S Hutchinson, J Ailani, ML Reed, KM Fanning, ... Headache: The Journal of Head and Face Pain 59 (10), 1762-1772, 2019 | 44 | 2019 |
Richard B.Lipton, M.D.Professor of Neurology, Albert Einstein College of Medicine在 einsteinmed.org 的电子邮件经过验证
